6Srivastava RK, Sasaki CY, Marie Hardwick J, et al. Bcl-2- mediated drug resistance: inhibition of apoptosis by blocking nuclear factord activated T lymphocytes(NFAT) - induced Fas ligand transcription[J]. J Exp Med, 1999,190(2):253-266.
7Chakraborti T, Kim KA, Goldstein GG, et al. Increased AP- 1 DNA binding activity in PC12 cells treated with lead[J]. J Neurochem,1999,73( 1 ) : 187 - 194.
8Sheehan J-P, Swerdlow RH, Pankcr WD, et al. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Paddnson's disease[J].J Neurochem, 1997,68(3):1221 - 1233.
9Bossy - Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c realease in apoptosis occurs upstream M DEVD - specific caspase activation and independently of mitochondrial transmembrance depolarization[J]. EMBO J, 1998,17( 1 ) :37 - 39.
10Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death[J]. Blood, 1996,88(2):386-401.
8Srivastava RK,Sasaki CY,Marie Hardwick J,et al.Bcl-2-mediated drug resistance:inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription[J].J EXP Med,1999,190(2):253-266.
9Chakraborti T,Kim KA,Goldstein GG,et al.Increased AP-1 DNA binding activity in PC12 cell treated with lead[J].J Neurochern,1999,73(1):187-194.
10Dauer W,Przedborski S.Parkinson's disease:mechanisms and models[J],Neuron,2003,39(6):889-909.
